(Q53993764)

23 May 2018

title

Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer. (English)

1 reference

23 May 2018

author name string

Weiwei Li

1

1 reference

23 May 2018

Ming Jia

2

1 reference

23 May 2018

Xiaomin Qin

3

1 reference

23 May 2018

Jing Hu

4

1 reference

23 May 2018

Xiaofang Zhang

5

1 reference

23 May 2018

Gengyin Zhou

6

1 reference

23 May 2018

language of work or name

English

0 references

publication date

8 October 2013

1 reference

23 May 2018

published in

FEBS Journal

1 reference

23 May 2018

volume

280

1 reference

23 May 2018

issue

23

1 reference

23 May 2018

page(s)

6128-6140

1 reference

23 May 2018

Estrogen carcinogenesis in breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Estrogen receptors and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Estrogen receptor-beta and breast cancer: translating biology into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

The role of estrogen receptor-β in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

ERbeta in breast cancer--onlooker, passive player, or active protector?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Estrogen receptor beta acts as a dominant regulator of estrogen signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

ERbeta exerts multiple stimulative effects on human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

ABCG2: determining its relevance in clinical drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Breast cancer resistance protein expression and 5-fluorouracil resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Membrane topology of the human breast cancer resistance protein (BCRP/ABCG2) determined by epitope insertion and immunofluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Progesterone receptor downregulates breast cancer resistance protein expression via binding to the progesterone response element in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

F-box protein Skp2: a novel transcriptional target of E2F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Estrogen receptor beta expression in invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Estrogen receptor beta in breast cancer--diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Estradiol receptors in breast cancer cells: associated co-factors as targets for new therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12533

21 January 2018

Identifiers

DOI

10.1111/FEBS.12533

1 reference

23 May 2018

1 reference

23 May 2018